Priyam Shah | executive |
Brian McKelligon | executive |
John Ek | executive |
Kyle Mikson | analyst |
David Westenberg | analyst |
Mark Massaro | analyst |
Tejas Savant | analyst |
Subhalaxmi Nambi | analyst |
Racheal Vatnsdal | analyst |
Mason Carrico | analyst |
Timothy Chiang | analyst |
Good day, and thank you for standing by. Welcome to the Akoya Biosciences First Quarter 2024 Earnings Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded. I would now like to turn the conference over to your speaker, Priyam Shah, Head of Investor Relations.